Literature DB >> 24506938

Polycystic liver disease: ductal plate malformation and the primary cilium.

Edgar S Wills1, Ronald Roepman2, Joost P H Drenth3.   

Abstract

Polycystic livers are found in autosomal dominant polycystic kidney disease (ADPKD), caused by polycystic kidney disease (PKD)1 and PKD2 mutations in virtually all cases, and in isolated polycystic liver disease (PCLD), where 20% of cases are caused by mutations in Protein kinase C substrate 80K-H (PRKCSH) or SEC63. Loss of heterozygosity in single hepatoblasts leads to underlying cystogenic ductal plate malformations. Crucially, actual components driving this development remain elusive. Recent advances have unraveled the roles of transforming growth factor (TGF)-β, Notch and Wnt signaling, transcriptional regulators such as hepatocyte nuclear factor (HNF)6 and HNF1β, as well as cilium function in hepatobiliary organogenesis. In polycystic liver disease, mutation or defective co-translational processing of key elements required for primary cilium formation have been implicated. This review recapitulates liver patterning factors in hepatobiliary development and extracts molecular players in hepatic cystogenesis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ductal plate malformation; hepatic cystogenesis; hepatobiliary organogenesis; loss of heterozygosity; polycystic liver disease; primary cilium

Mesh:

Substances:

Year:  2014        PMID: 24506938     DOI: 10.1016/j.molmed.2014.01.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  27 in total

1.  TGR5 in the Cholangiociliopathies.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 2.  MicroRNAs and benign biliary tract diseases.

Authors:  Sergio A Gradilone; Steven P O'Hara; Tetyana V Masyuk; Maria Jose Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  Polycystic liver diseases: advanced insights into the molecular mechanisms.

Authors:  Maria J Perugorria; Tatyana V Masyuk; Jose J Marin; Marco Marzioni; Luis Bujanda; Nicholas F LaRusso; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 46.802

4.  Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Authors:  Edgar S Wills; Wybrich R Cnossen; Joris A Veltman; Rob Woestenenk; Marloes Steehouwer; Jody Salomon; René H M Te Morsche; Meritxell Huch; Jayne Y Hehir-Kwa; Martijn J Banning; Rolph Pfundt; Ronald Roepman; Alexander Hoischen; Joost P H Drenth
Journal:  Eur J Hum Genet       Date:  2016-08-24       Impact factor: 4.246

Review 5.  Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease.

Authors:  Ming Ma; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

6.  Isolated polycystic liver disease genes define effectors of polycystin-1 function.

Authors:  Whitney Besse; Ke Dong; Jungmin Choi; Sohan Punia; Sorin V Fedeles; Murim Choi; Anna-Rachel Gallagher; Emily B Huang; Ashima Gulati; James Knight; Shrikant Mane; Esa Tahvanainen; Pia Tahvanainen; Simone Sanna-Cherchi; Richard P Lifton; Terry Watnick; York P Pei; Vicente E Torres; Stefan Somlo
Journal:  J Clin Invest       Date:  2017-04-04       Impact factor: 14.808

7.  TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases through cyclic adenosine monophosphate/Gαs signaling.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Maria Lorenzo Pisarello; Brynn N Howard; Bing Q Huang; Pui-Yuen Lee; Xavier Fung; Eduard Sergienko; Robert J Ardecky; Thomas D Y Chung; Anthony B Pinkerton; Nicholas F LaRusso
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

Review 8.  Therapeutic Targets in Polycystic Liver Disease.

Authors:  Tatyana V Masyuk; Anatoliy I Masyuk; Nicholas F LaRusso
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

9.  Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.

Authors:  Romina Mancinelli; Antonio Franchitto; Shannon Glaser; Antonella Vetuschi; Julie Venter; Roberta Sferra; Luigi Pannarale; Francesca Olivero; Guido Carpino; Gianfranco Alpini; Paolo Onori; Eugenio Gaudio
Journal:  Lab Invest       Date:  2016-08-29       Impact factor: 5.662

10.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.